Tasco/Bio-Matrix may become the first company to operate an adipose-derived stem cell bank in the United States. Stem cells which are derived from fat tissues can easily, and ethically be harvested by elective liposuction, which is then stored in a frozen condition in liquid nitrogen at super-cooled temperatures. When needed, these stem cells can be thawed to potentially treat several diseases. The banking of cord blood is a once in a lifetime opportunity, which can only be done at the time of birth. However, by offering to preserve stem cells from adipose tissue, the company has significantly expanded its customer base.
Tasco/Bio-Matrix believes that though cord blood banking will help the company to generate earnings, the adipose tissue derived from stem cells will be its major source of earnings. Additionally, stem cell therapy commands the need for instrumentation, which is less invasive and friendly to both the target area as well as the tissue and cells. Tasco/Bio-Matrix has developed a full line of such disposable stem cell extraction surgical tools, which can be used to extract, transfer and re-introduce cells.
Given the growing number of liposuctions, demand for both the instruments as well as the company’s cryogenic storage facility is bound to increase. Given the immense opportunity in the stem cell research segment of the $75 billion growing biotechnology and medical device industry, the upcoming building in the heart of San Diego should help Tasco/Bio-Matrix generate significant earnings going forward.
About Tasco Holdings Inc.
Tasco Holdings Inc. recently purchased Bio-Matrix Scientific Group Inc. (www.BMXGonline.com), a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.
The Company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in San Diego, California, to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.
Source:
Beacon Equity Research – http://www.BeaconEquityResearch.com
Safe Harbor Provision: This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements include “…will also allow us to expand the market for the Ginger Kelly Collection beyond North America, thereby greatly increasing shareholder value” and are based on the Company’s current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. Risk factors include, lack of inventory financing, foreign currency fluctuations, availability of product, uncertainty concerning market acceptance of its products, competition and other risk factors as outlined in the Company’s SEC filings.
Forward Looking Statement: The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements to the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward- looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development and acceptance, the impact of competitive services and pricing, or general economic risks and uncertainties.
Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 453-4258. Web: StockGuru.com. Email: http://www.stockguru.com/blog/Publisher@Stockguru.com.
Disclosure: Pentony Enterprises LLC was compensated $10,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this.
Tasco Holdings International:
Bio-Matrix Scientific Group Inc
David Koos, 619-398-3517
